基因表达变异与寄生虫载量预测皮肤利什曼病治疗转归
对接受五价锑治疗前的皮肤利什曼病患者的病灶活检进行转录组分析,发现患者间高变异表达的基因与治疗转归相关,其中细胞溶解通路组分的表达与皮肤寄生虫载量相关。治疗失败与感染期间激活的细胞溶解通路相关,用少至三个基因的宿主-病原体标志物特征可在两个独立队列(n=21和n=25)中于治疗前预测最终治疗转归。
要点
- 患者间高变异表达的基因与皮肤利什曼病治疗转归相关。
- 细胞溶解通路组分表达变异大,且与皮肤寄生虫载量相关。
- 治疗失败与感染期间激活的细胞溶解通路相关,三基因标志物可在治疗前预测转归。
核心结论
- 治疗失败与感染期间激活的细胞溶解通路相关。
- 使用少至三个基因的宿主-病原体标志物特征,可在两个独立队列中于治疗开始前预测最终治疗转归。
研究设计与样本
- 获取患者接受五价锑治疗前的病灶活检,对这些临床样本进行转录组分析。
- 在两个独立皮肤利什曼病患者队列(n=21和n=25)中评估三基因宿主-病原体标志物特征对治疗转归的预测能力。
主要发现
- 鉴定出患者间高度变异表达的基因,这些基因的变异表达与治疗转归相关。
- 在所有患者中变异最大的基因包括细胞溶解通路的组分,这些基因的表达与皮肤寄生虫载量相关。
- 治疗失败与感染期间激活的细胞溶解通路相关。
- 使用少至三个基因的宿主-病原体标志物特征,可在两个独立队列(n=21和n=25)中于治疗开始前预测最终治疗转归。
关键数值与推荐
- 三基因宿主-病原体标志物特征可在治疗前预测皮肤利什曼病治疗转归,两个独立队列样本量分别为n=21和n=25。
临床怎么用
- 这些发现提出了通过即时诊断筛查识别治疗失败高风险患者的可能性。
- 这些发现为皮肤利什曼病药物选择的精准医学方法提供了依据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients infected with Leishmania braziliensis develop chronic lesions that often fail to respond to treatment with antiparasite drugs. To determine whether genes whose expression is highly variable in lesions between patients might influence disease outcome, we obtained biopsies of lesions from patients before treatment with pentavalent antimony and performed transcriptomic profiling on these clinical samples. We identified genes that were highly variably expressed between patients, and the variable expression of these genes correlated with treatment outcome. Among the most variable genes in all the patients were components of the cytolytic pathway, and the expression of these genes correlated with parasite load in the skin. We demonstrated that treatment failure was linked to the cytolytic pathway activated during infection. Using a host-pathogen marker profile of as few as three genes, we showed that eventual treatment outcome could be predicted before the start of treatment in two separate cohorts of patients with cutaneous leishmaniasis (n = 21 and n = 25). These findings raise the possibility of point-of-care diagnostic screening to identify patients at high risk of treatment failure and provide a rationale for a precision medicine approach to drug selection in cutaneous leishmaniasis. This work more broadly demonstrates the value of identifying genes of high variability in other diseases to better understand and predict diverse clinical outcomes.
引用
- Amorim CF, Novais FO, Nguyen BT, et al. Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis. Sci Transl Med. 2019. PMID: 31748229. doi:10.1126/scitranslmed.aax4204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。